THX Pharma Société Anonyme (EPA:ALTHX)
France flag France · Delayed Price · Currency is EUR
4.205
-0.095 (-2.21%)
Aug 3, 2026, 3:14 PM CET

EPA:ALTHX Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3-1.77-6.83-6.57-8.15
Depreciation & Amortization
0.110.10.260.331.16
Other Adjustments
0.27-2.29-0.09-0.30.44
Change in Receivables
0.16-0.560.321.070.54
Changes in Accounts Payable
1.641.15-0.060.1-0.14
Operating Cash Flow
-0.82-3.37-6.4-5.37-6.14
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.06-0-0-0.04-0.02
Sale of Property, Plant & Equipment
0.040.1---
Purchases of Intangible Assets
-0.2-0.03-0.04-0.03-0.14
Purchases of Investments
---0.02-0.02-
Proceeds from Sale of Investments
0.050.01-0.42-
Investing Cash Flow
-0.170.08-0.060.32-0.15

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----0.3
Long-Term Debt Repaid
-0.17-1.11-1.46-1.04-0.77
Net Long-Term Debt Issued (Repaid)
-0.17-1.11-1.46-1.04-0.47
Issuance of Common Stock
7.220.342.930.688.15
Net Common Stock Issued (Repurchased)
7.220.342.930.688.15
Other Financing Activities
-0.060.070.04-0.04-0.07
Financing Cash Flow
7.79-0.652.221.637.61

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
6.8-3.94-4.2-3.421.31

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-0.88-3.37-6.41-5.41-6.16
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.06-0.39-0.83-1.01-1.22
Levered Free Cash Flow
-1.48-1.63-8.09-7.22-7.62
Unlevered Free Cash Flow
-1.35-0.58-6.65-5.33-6.82